(Q54477690)

English

Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

immunohistochemistry

1 reference

based on heuristic

inferred from title

reproducibility

1 reference

based on heuristic

inferred from title

Erik Thunnissen

1

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Daniëlle A M Heideman

3

object named as

Daniëlle A M Heideman

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

author name string

Evan Boers

2

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Katrien Grünberg

4

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Dirk J Kuik

5

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Arnold Noorduin

6

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Matthijs van Oosterhout

7

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Divera Pronk

8

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Cees Seldenrijk

9

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Hannie Sietsma

10

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Egbert F Smit

11

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Robertjan van Suylen

12

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Jan von der Thusen

13

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Bart Vrugt

14

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Anne Wiersma

15

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Birgit I Witte

16

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Michael den Bakker

17

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

publication date

12 October 2012

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Virchows Archiv

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

461

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

6

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

629-638

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

https://scigraph.springernature.com/pub.10.1007/s00428-012-1324-x

0 references

Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

How reliable is the diagnosis of lung cancer using small biopsy specimens? Report of a UKCCCR Lung Cancer Working Party

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Observer variability in histopathological reporting of non-small cell lung carcinoma on bronchial biopsy specimens

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Observer variability in histopathological reporting of malignant bronchial biopsy specimens

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Large cell carcinoma of the lung: an endangered species?

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

P63 expression in lung carcinoma: a tissue microarray study of 408 cases

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Abnormalities of epidermal growth factor receptor in lung squamous-cell carcinomas, adenosquamous carcinomas, and large-cell carcinomas: tyrosine kinase domain mutations are not rare in tumors with an adenocarcinoma component.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Identification of EGFR kinase domain mutations among lung cancer patients in China: implication for targeted cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Association of epidermal growth factor receptor activating mutations with low ERCC1 gene expression in non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Epidermal growth factor receptor mutations and the clinical outcome in male smokers with squamous cell carcinoma of lung

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

ΔNp63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer: A Novel Two-Hit, Sparing-Material Approach

1 reference

https://api.crossref.org/works/10.1007%2FS00428-012-1324-X

21 January 2018

Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23064619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A panel of high resolution melting (HRM) technology-based assays with direct sequencing possibility for effective mutation screening of EGFR and K-ras genes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23064619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morphology and a limited number of immunohistochemical markers may efficiently subtype non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23064619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lung cancer staging. A critical evaluation.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23064619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A fast, sensitive and accurate high resolution melting (HRM) technology-based assay to screen for common K-ras mutations.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23064619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large cell carcinoma of the lung.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23064619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products

1 reference

https://pubmed.ncbi.nlm.nih.gov/23064619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype

1 reference

https://pubmed.ncbi.nlm.nih.gov/23064619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

TTF-1, cytokeratin 7, 34betaE12, and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung

1 reference

https://pubmed.ncbi.nlm.nih.gov/23064619

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00428-012-1324-X

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

release_4fx7z5eaozbxboc4yy6occ6ad4

1 reference

https://api.fatcat.wiki/v0/release/4fx7z5eaozbxboc4yy6occ6ad4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 May 2018

http://europepmc.org/abstract/MED/23064619

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54477690&oldid=1843489870"